Antibodies against tim3 and uses thereof
US-2025326841-A1 · Oct 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Korman Alan J patents
Korman Alan J is listed as an inventor on 173 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Korman Alan J |
| Total patents | 173 |
| First publication | Jun 18, 2015 |
| Latest publication | Oct 23, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibodies binding to ILT4
US-12435136-B2 · Oct 7, 2025 · US
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins
US-2025236650-A1 · Jul 24, 2025 · US
Antibodies Binding to Vista at Acidic pH
US-2025206822-A1 · Jun 26, 2025 · US
Methods of treating cancer with antibodies against tim3
US-2025197494-A1 · Jun 19, 2025 · US
Antibodies against TIM3 and uses thereof
US-12312403-B2 · May 27, 2025 · US
Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumors
US-2025163155-A1 · May 22, 2025 · US
Compositions comprising a combination of an anti-lag-3 antibody, a pd-1 pathway inhibitor, and an immunotherapeutic agent
US-2025163152-A1 · May 22, 2025 · US
Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
US-2025154254-A1 · May 15, 2025 · US
Antibodies Binding to Vista at Acidic pH
US-2025129166-A1 · Apr 24, 2025 · US
Recent patents
Latest publications not already listed above.
Antibodies against tim3 and uses thereof
US-2025115664-A1 · Apr 10, 2025 · US
Anti-nkg2a antibodies and uses thereof
US-2025101100-A1 · Mar 27, 2025 · US
Antibodies binding to VISTA at acidic pH
US-12195535-B2 · Jan 14, 2025 · US
Antibodies binding to vista at acidic pH
US-12173069-B2 · Dec 24, 2024 · US
Antibodies against TIM3 and uses thereof
US-12129297-B2 · Oct 29, 2024 · US
Anti-CD27 antibodies and uses thereof
US-12110337-B2 · Oct 8, 2024 · US
Antibodies binding to vista at acidic pH
US-12091462-B2 · Sep 17, 2024 · US
Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)
US-12077584-B2 · Sep 3, 2024 · US
Antibodies against tim3 and uses thereof
US-2024209083-A1 · Jun 27, 2024 · US
Methods of treating cancer with antibodies against tim3
US-2024174749-A1 · May 30, 2024 · US
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
US-2024158524-A1 · May 16, 2024 · US
Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
US-11981734-B2 · May 14, 2024 · US
Antibodies Binding to VISTA at Acidic pH
US-2024092907-A1 · Mar 21, 2024 · US
Anti-icos agonist antibodies and uses thereof
US-2024041995-A1 · Feb 8, 2024 · US
Antibodies against tim3 and uses thereof
US-2023382992-A1 · Nov 30, 2023 · US
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
US-11802162-B2 · Oct 31, 2023 · US
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
US-2023322919-A1 · Oct 12, 2023 · US
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins
US-2023287064-A1 · Sep 14, 2023 · US
Monoclonal Antibodies to Programmed Death 1 (PD-1)
US-2023272079-A1 · Aug 31, 2023 · US
Antibodies against ox-40 and uses thereof
US-2023272100-A1 · Aug 31, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 121 |
| Squibb & Sons Llc | 60 |
| Five Prime Therapeutics Inc | 14 |
| Ono Pharmaceutical Co | 10 |
| Medarex Llc | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 164 |
| A61K2039/505 | 157 |
| C07K2317/92 | 149 |
| C07K2317/21 | 145 |
| C07K2317/76 | 135 |